Skip to main content
OpenTrials
Completed

NCT Number: NCT03792685

Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention

The objectives of this trial are to assess the effects of interactions between genetic factors and diet with various macronutrient intake on the metabolic disorders, obesity and type 2 diabetes risk, prevention, development and progress.

Completed

Looking for future studies?

Notify Me

Key information

About this study

This is a randomized, crossover study that includes 1 screening visit and four meal challenge test visits, separated by a 1-2-weeks washout period. The screening will include 2000 people, males and females, to evaluate the genotype frequencies in studied population, and to find carriers of the rare genetic single nucleotide polymorphisms (SNPs), who will fulfill all the other inclusion criteria. An oral glucose tolerance test (OGTT) will be completed at screening visit. Moreover, the fasting blood samples will be collected for genetic analysis, and measurements of blood glucose and lipid metabolism profile, high-sensitivity C-reactive protein (hs-CRP), hormones/peptides and other factors involved in energy balance regulation. Subjects will be asked to record their daily food intake for 3 days. Assessments of vital signs and body height and weight, waist and hip circumferences, body fat content and body fat distribution, review of concomitant medication/supplement use and inclusion and exclusion criteria, and evaluation of adverse effects will be performed throughout the study. To meal challenge test only men will be included, since the sex hormones may influence the study endpoints. Subjects will be encouraged to maintain their habitual diet during wash-out periods. During the each meal challenge test subjects will consume one of the study meals in random order. The blood will be collected at fasting state and 30, 60, 120, 180 and 240 minutes after meal intake. The energy expenditure and substrate utilization will be measured by indirect calorimetry method at the fasting and postprandially.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy men with normal body weight and with overweight/obesity
  • men with metabolic syndrome, hypertension, type 2 diabetes newly diagnosed, or not treated with any medicines
  • maintaining the usual diet and lifestyle throughout the study

Exclusion criteria

  • infectious or acute diseases in the last 4 weeks before the study visits
  • any medicines/dietary supplements consumption in the last 4 weeks before the study visits
  • high level of daily physical activity
  • the following any special diet or dietary patterns (vegetarian, high-fat etc.)
  • the presence of any other significant disease which may affect the results (hormonal disorders, history of any surgeries on gastrointestinal tract, allergies known or suspected, heart failure, history of cancer, any kidney, pancrea and liver diseases, except non-alcoholic fatty liver)
  • abusive alcohol consumption
  • abusive coffee or energy drinks consumption
  • drug consumption

Treatment and study plan

Normo-carbohydrate meal intake

Other

Subjects are going to receive the normo-carbohydrate meal.

High-carbohydrate meal intake

Other

Subjects are going to receive the high-carbohydrate meal.

High-fat meal intake

Other

Subjects are going to receive the high-fat meal.

High-protein meal intake

Other

Subjects are going to receive the high-protein meal.

Primary outcomes

  1. The postprandial change and differences in blood glucose levels associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in blood glucose concentrations (mg/dL) will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  2. The postprandial change and differences in serum insulin concentrations associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in serum insulin concentrations (IU/mL) will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content)

  3. The change and differences in postprandial Triglycerides (TGs) concentrations associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in blood TGs (mg/dL) concentrations will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  4. The change and differences in postprandial Free Fatty Acids (FFAs) concentrations associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in blood FFAs (umol/L) concentrations will be evaluated, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  5. The change and differences in postprandial energy expenditure levels associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in energy expenditure levels (kcal/min) will be evaluated by indirect calorimetry method, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  6. The change and differences in postprandial substrates (carbohydrate, fat and protein) utilization levels associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in substrates (carbohydrate, fat and protein) utilization (mg/min) will be evaluated by indirect calorimetry method, dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

Secondary outcomes

  1. The change and differences in postprandial ghrelin concentrations associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in blood ghrelin concentrations (pg/mL) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  2. The change and differences in postprandial leptin concentrations associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in blood leptin concentrations (ng/mL) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  3. The change and differences in postprandial adiponectin concentrations associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180, 240 minutes after meal intake.

    The postprandial change and differences in blood adiponectin concentrations (ng/mL) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  4. The change and differences in postprandial peptide YY (PYY) concentrations associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180 minutes after meal intake.

    The postprandial change and differences in blood PYY (pg/mL) concentrations will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

  5. The change and differences in postprandial plasma metabolites profiles associated with investigated single nucleotide polymorphisms.

    Time frame: Fasting (time 0) and 30, 60, 120, 180 minutes after meal intake.

    The postprandial change and differences in plasma metabolites profiles (metabolomic fingerprinting) will be evaluated dependently on the meal type, genetic and metabolic (body weight, body fat content) factors.

Sponsors and collaborators

Lead sponsor

Medical University of Bialystok

Other

Collaborators

  • Ministry of Science and Higher Education, Poland

Registry information

Official study title

Analysis of Genetic Aspects of Metabolic Response on Diet With Different Content of Carbohydrate and Fat. Searching for Genetic Markers for Individualized Therapy in Patients With Obesity and Type 2 Diabetes

Important dates

Study start
2009
Primary completion
2020
Study completion
2021
First posted
Jan 3, 2019
Registry last updated
Feb 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.